Lecturer: Xiao Ting
Time: March 19, 2024, 10:00 am
Location: 227, Laboratory Building No.1, North Zone
Lecturer Introduction:
Xiao Ding, National Cancer Center/Chinese Academy of Medical Sciences Tumor Hospital, Peking Union Medical College, researcher and PhD supervisor. His research focuses on the molecular mechanisms and molecular signatures of malignant tumor development, focusing on clinical proteomics, exploring biomarkers for tumor diagnosis and treatment and prognosis monitoring, discovering new anti-tumor drug targets, and focusing on the translation of scientific research results into clinical applications. Over the past 20 years, he has gradually formed a close and stable team of multidisciplinary researchers in basic oncology, surgical oncology, pathology, imaging and other areas of basic research and clinical practice. He has presided over the National Key Research and Development Program (NKRDP), National Natural Science Foundation of China (two at the surface and one at the youth level), Beijing Natural Science Foundation of China (one at the surface level), and the Fund for the Authors of Hundred Outstanding Doctoral Dissertations of China as the leader of the research projects. He has also participated in the projects of the National 973 and 863 Programs, the Key Special Project on Precision Medicine of NKRDP, and the Science and Technology Innovation Project of Medicine and Health of the Academy of Sciences of China as the key researcher of the projects. He has published more than 20 SCI papers as the first/corresponding author, including Cell (ESI highly cited papers), Signal Transduct Target Ther, etc. He has authorized 6 patents. He has been authorized 6 national invention patents. He was awarded the first prize of Concordia Rising Star, the first prize of Science and Technology Award of Chinese Society of Preventive Medicine, the Important Medical Advancement in China 2020, the Young Cadre Award of “Leader and Role Model” of Cancer Hospital of the Chinese Academy of Medical Sciences in 2018, and the “Star of Hope” of the Talent Incentive Program of Cancer Hospital of the Chinese Academy of Medical Sciences in 2022, and so on. Star” of the Talent Incentive Program of Cancer Hospital of Chinese Academy of Medical Sciences in 2022, and other awards and honors.
